Agios Pharm (AGIO)
$43.37 -$2.10 (-4.55%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$3.52B -
Day's Range
$43.73 - $46.68 -
Volume
862,347 -
52 Week Low / High
$20.96 - $62.58 -
PE Ratio
5.29x -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 3
- Strong Buy
- 4
- Buy
- 3
- Hold
- 0
- Sell
- 0
- Strong Sell
- $39.00
- Target Price
Company News
-
Do Options Traders Know Something About Agios (AGIO) Stock We Don't? — Sep 27th, 2024
Investors in Agios Pharmaceuticals, Inc. AGIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 20, 2024 $17.50 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied vol...
-
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 — Oct 17th, 2024
Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on...
-
Do Options Traders Know Something About Agios (AGIO) Stock We Don't? — Sep 27th, 2024
Investors in Agios Pharmaceuticals, Inc. AGIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 20, 2024 $17.50 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied vol...
-
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 — Oct 17th, 2024
Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on...
-
Do Options Traders Know Something About Agios (AGIO) Stock We Don't? — Sep 27th, 2024
Investors in Agios Pharmaceuticals, Inc. AGIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 20, 2024 $17.50 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied vol...
-
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 — Oct 17th, 2024
Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on...
-
Do Options Traders Know Something About Agios (AGIO) Stock We Don't? — Sep 27th, 2024
Investors in Agios Pharmaceuticals, Inc. AGIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 20, 2024 $17.50 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied vol...
-
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 — Oct 17th, 2024
Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on...
-
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 — Oct 17th, 2024
Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on...
-
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 — Oct 17th, 2024
Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on...
-
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 — Oct 17th, 2024
Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on...
-
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 — Oct 17th, 2024
Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on...
-
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 — Oct 17th, 2024
Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on...
Similar Stocks
Portfolio
Comprised of 1 portfolios